Jove
Visualize
联系我们

相关实验视频

干扰因复发性缓解性多发性硬化症的干扰.

Mark Freedman, John King, Joel Oger

    Lancet (London, England)
    |June 5, 2003
    PubMed
    概括

    No abstract available in PubMed .

    相关实验视频

    相关概念视频

    您也可能阅读

    相关文章

    通过共同作者、期刊和引用图与本文相关的文章。

    排序
    Same author

    The introduction of new medications in pediatric multiple sclerosis: Open issues and challenges.

    Multiple sclerosis (Houndmills, Basingstoke, England)·2020
    Same author

    Merits and culprits of immunotherapies for neurological diseases in times of COVID-19.

    EBioMedicine·2020
    Same author

    [Ocrelizumab for treatment of multiple sclerosis].

    Der Nervenarzt·2020
    Same author

    Ocrelizumab shorter infusion: Primary results from the ENSEMBLE PLUS substudy in patients with MS.

    Neurology(R) neuroimmunology & neuroinflammation·2020
    Same author

    Clinical implications of serum neurofilament in newly diagnosed MS patients: A longitudinal multicentre cohort study.

    EBioMedicine·2020
    Same author

    COVID-19 and management of neuroimmunological disorders.

    Nature reviews. Neurology·2020
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    关于 JoVE
    概览领导团队博客JoVE 帮助中心
    作者
    出版流程编辑委员会范围与政策同行评审常见问题投稿
    图书馆员
    用户评价订阅访问资源图书馆顾问委员会常见问题
    研究
    JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
    教育
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
    使用条款与条件
    隐私政策
    政策